News for hackers. Stuff that matters.
Re:Medicare Millionaires Emerge in Data on Doctor Payments by refurb on Wednesday April 09, 2014 @11:16AM (#7559771)
True! It's not a straight salary and docs do have expenses they need to pay out of that money.

I was just trying to call out that the cost of supplies and facility fees are paid by Medicare separately.

Re:Medicare Millionaires Emerge in Data on Doctor Payments by riahi on Wednesday April 09, 2014 @11:27AM (#7559861)
This does not include cost of injectable or infused drugs. These are not paid separately by Medicare.
Re:Medicare Millionaires Emerge in Data on Doctor Payments by refurb on Wednesday April 09, 2014 @11:30AM (#7559884)
Sure they are! If you're an in-patient then drugs are paid for via the DRG payment (all costs associated with treating the patient). If you're an out-patient, they are reimbursed through ASP.

The physician fee is separate from these payments.

Re:Medicare Millionaires Emerge in Data on Doctor Payments by riahi on Wednesday April 09, 2014 @11:50AM (#7560043)
I'm skeptical for these ophthalmologists to be billing those numbers and NOT include the average sales price (ASP) of their injectable drugs.

For those looking in, ASP is how medicare reimburses outpatient drugs. The physician practice buys the drugs up front, then bills Medicare the "average sales price" + 6%. The issue at hand is that Lucentis runs $2120 per injection. If you have a decent or large sized macular degeneration patient population, you'll be doing a lot of these injections. However, the number the practice collects is $320. Out of that number, you have to pay overhead / office staff / supplies etc.

Re:Medicare Millionaires Emerge in Data on Doctor Payments by refurb on Wednesday April 09, 2014 @12:04PM (#7560158)
I just downloaded one of the excel sheets and I only see procedures on the list, no drugs, but your suspicion is warranted.

The other thing to remember is that if it did include ASP reimbursement, ophthalmologists wouldn't be at the top, oncologists would. If a cancer doc saw 200 HER2 positive breast cancer patients in one year (16/month), treating them with Herceptin alone would cost $14,000,000. Most docs I've spoken to see 100-200 cancer patients per month (of course not all get treated with expensive drugs).

Re:Medicare Millionaires Emerge in Data on Doctor Payments by riahi on Wednesday April 09, 2014 @12:30PM (#7560356)
Yes, but you have to remember that these are Medicare data. The prevalence of 65+ patients getting Her2+ breast cancer AND getting treatment with Herceptin is probably lower than the number of 65+ patients getting ARMD and going on treatment with Lucentis.

Unfortunately, I don't have a good source. The above is merely my speculation.